Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs AquaVita NextGen

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and AquaVita NextGen head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 212 · Grade C

AquaVita NextGen

Visit AquaVita NextGen Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 67 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make AquaVita NextGen a bad call — it's best for readers who can get an itemized quote before choosing a program. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
36
Supply Reliability
95
71
Transparency
90
88
Access Breadth
93
62
Clinical Oversight
92
82
Track Record
88
73
CoreAge RxBrief Score 94 · 67AquaVita NextGen

Price, coverage & the tracker

CoreAge RxAquaVita NextGen
Brief Score94/100 (A)67/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Complete cost unknown. Advertised at $375 for the first month. Recurring price unconfirmed.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Current public price unconfirmed.

CoverageUS only; restrictions by state, confirmed at intakeConfirm prescribing and pharmacy availability for your address.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

AquaVita NextGen: The advertised semaglutide price applies to the first month. Confirm later charges.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.